Cargando…

PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells

SIMPLE SUMMARY: Colorectal cancer (CRC) represents a heterogeneous population of tumor cells and cancer stem cells (CSCs) where CSCs are postulated to resist the chemotherapy, and support cancer malignancy. Eliminating CSC can therefore improve CRC therapy and patient survival; however, such strateg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Balawant, Ahmad, Rizwan, Sharma, Swagat, Gowrikumar, Saiprasad, Primeaux, Mark, Rana, Sandeep, Natarajan, Amarnath, Oupicky, David, Hopkins, Corey R., Dhawan, Punita, Singh, Amar B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124755/ https://www.ncbi.nlm.nih.gov/pubmed/33946505 http://dx.doi.org/10.3390/cancers13092168

Ejemplares similares

Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019)

MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
por: Uppada, Srijayaprakash Babu, et al.
Publicado: (2018)

Upregulated Claudin-1 Expression Promotes Colitis-associated Cancer by promoting β-Catenin phosphorylation and activation in Notch/p-AKT Dependent Manner
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019)

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
por: Gowrikumar, Saiprasad, et al.
Publicado: (2021)

HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation
por: Ahmad, Rizwan, et al.
Publicado: (2017)

Colonoscopy-based intramucosal transplantation of cancer cells for mouse modeling of colon cancer and lung metastasis
por: Ahmad, Rizwan, et al.
Publicado: (2021)

Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling
por: Ahmad, Rizwan, et al.
Publicado: (2017)

Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
por: Kumar, Balawant, et al.
Publicado: (2021)

P62/SQSTM1 binds with claudin-2 to target for selective autophagy in stressed intestinal epithelium
por: Ahmad, Rizwan, et al.
Publicado: (2023)

Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications
por: Ahmad, Rizwan, et al.
Publicado: (2016)

Cocaine Induces Inflammatory Gut Milieu by Compromising the Mucosal Barrier Integrity and Altering the Gut Microbiota Colonization
por: Chivero, Ernest T., et al.
Publicado: (2019)

Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing
por: Ahmad, Rizwan, et al.
Publicado: (2023)

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations
por: Moon, Jai-Hee, et al.
Publicado: (2019)

PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor
por: Liu, Fengchao, et al.
Publicado: (2020)

Claudin Family of Proteins and Cancer: An Overview
por: Singh, Amar B., et al.
Publicado: (2010)

MASTL: A novel therapeutic target for Cancer Malignancy
por: Fatima, Iram, et al.
Publicado: (2020)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Carcinogenesis by Modulating Microtubule-Associated Serine/Threonine Kinase-like/Wnt/β-Catenin Signaling
por: Lama Tamang, Raju, et al.
Publicado: (2023)

Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells
por: Barman, Susmita, et al.
Publicado: (2021)

MicroRNA-126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer
por: SONG, LEI, et al.
Publicado: (2016)

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come
por: De Mattos-Arruda, Leticia
Publicado: (2020)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

Obesity-induces Organ and Tissue Specific Tight Junction Restructuring and Barrier Deregulation by Claudin Switching
por: Ahmad, Rizwan, et al.
Publicado: (2017)

Small molecule induced polymerization of BCL6 facilitates SIAH1 mediated degradation
por: Rana, Sandeep, et al.
Publicado: (2021)

SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer
por: Lv, Yuesheng, et al.
Publicado: (2021)

MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3
por: Zhao, Jian, et al.
Publicado: (2022)

[Retracted] MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3
por: Zhang, Jian, et al.
Publicado: (2023)

Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis
por: Pope, Jillian L, et al.
Publicado: (2014)

Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway
por: Song, Hong Ki, et al.
Publicado: (2015)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors
por: Liu, Yane, et al.
Publicado: (2022)

Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition
por: Boku, Shogen, et al.
Publicado: (2020)

Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene
por: Wang, Xiaoqing, et al.
Publicado: (2020)

PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013)

PIK3R3 inhibits cell senescence through p53/p21 signaling
por: Chen, Qianzhi, et al.
Publicado: (2020)

Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition
por: López-Knowles, Elena, et al.
Publicado: (2014)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3ek39l04ql9bln9qdlptsa40f